CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Accounts and Other Receivables
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Accounts and Other Receivables of $165.40 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2026-06-30 was $151.38K, a 636.06% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2026-03-31 was $14.02K, a 91.49% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$13.51M, a 6444.99% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was $117.49K, a 29.77% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2025 was -$13.21M, a 6780.77% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2024 was $197.71K, a 78.92% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2023 was $938.02K, a 451.15% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2022 was $170.19K, a 68.80% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 6 month as first filed | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 9 month as first filed | Increase (Decrease) in Accounts and Other Receivables 12 month | Increase (Decrease) in Accounts and Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $151.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $165.40K 10-Q · filed 2026-08-14 | -$13.35M derived: sum of 3 quarters · filed 2026-08-14 | -$13.23M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $14.02K 10-Q · filed 2026-05-15 | -$13.50M derived: sum of 2 quarters · filed 2026-05-15 | -$13.38M derived: sum of 3 quarters · filed 2026-05-15 | -$13.36M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$13.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$13.39M derived: sum of 2 quarters · filed 2026-04-01 | -$13.37M derived: sum of 3 quarters · filed 2026-08-14 | -$13.21M 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | $117.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $138.06K derived: sum of 2 quarters · filed 2026-08-14 | $302.73K 10-Q · filed 2025-11-12 | $515.67K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $20.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $185.24K 10-Q · filed 2026-08-14 | $398.18K derived: sum of 3 quarters · filed 2026-08-14 | $565.48K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $164.67K 10-Q · filed 2026-05-15 | $377.61K derived: sum of 2 quarters · filed 2026-05-15 | $544.91K derived: sum of 3 quarters · filed 2026-05-15 | $482.75K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $212.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $380.24K derived: sum of 2 quarters · filed 2026-04-01 | $318.08K derived: sum of 3 quarters · filed 2026-04-01 | $197.71K 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | $167.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $105.14K derived: sum of 2 quarters · filed 2025-11-12 | -$15.23K 10-Q · filed 2025-11-12 | $349.02K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$62.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$182.53K 10-Q · filed 2025-08-14 | $181.72K derived: sum of 3 quarters · filed 2025-08-14 | $411.04K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$120.37K 10-Q · filed 2025-05-14 | $243.89K derived: sum of 2 quarters · filed 2025-05-14 | $473.20K derived: sum of 3 quarters · filed 2025-05-14 | $383.35K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $364.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $593.57K derived: sum of 2 quarters · filed 2025-03-31 | $503.71K derived: sum of 3 quarters · filed 2025-03-31 | $938.02K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $229.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $139.46K derived: sum of 2 quarters · filed 2024-11-13 | $573.76K 10-Q · filed 2024-11-13 | $681.05K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$89.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $344.45K 10-Q · filed 2024-08-14 | $451.74K derived: sum of 3 quarters · filed 2024-08-14 | $662.75K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $434.31K 10-Q · filed 2023-05-12 | $541.59K derived: sum of 2 quarters · filed 2024-04-01 | $752.61K derived: sum of 3 quarters · filed 2024-04-01 | $862.63K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | $107.29K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $318.30K derived: sum of 2 quarters · filed 2024-04-01 | $428.32K derived: sum of 3 quarters · filed 2024-04-01 | $170.19K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $211.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $321.04K derived: sum of 2 quarters · filed 2023-11-13 | $62.91K 10-Q · filed 2023-11-13 | $456.57K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $110.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$148.10K 10-Q · filed 2023-08-14 | $245.56K derived: sum of 3 quarters · filed 2023-08-14 | $276.67K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$258.13K 10-Q · filed 2023-05-12 | $135.53K derived: sum of 2 quarters · filed 2023-05-12 | $166.65K derived: sum of 3 quarters · filed 2023-05-12 | $11.58K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $393.66K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $424.78K derived: sum of 2 quarters · filed 2023-03-30 | $269.71K derived: sum of 3 quarters · filed 2023-03-30 | $545.53K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $31.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$123.95K derived: sum of 2 quarters · filed 2022-11-14 | $151.87K 10-Q · filed 2022-11-14 | $399.17K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$155.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $120.76K 10-Q · filed 2022-08-11 | $368.05K derived: sum of 3 quarters · filed 2022-08-11 | $429.25K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $275.82K 10-Q · filed 2022-05-12 | $523.11K derived: sum of 2 quarters · filed 2022-05-12 | $584.32K derived: sum of 3 quarters · filed 2022-05-12 | $548.33K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $247.29K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $308.50K derived: sum of 2 quarters · filed 2022-03-30 | $272.51K derived: sum of 3 quarters · filed 2022-03-30 | $613.68K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $61.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $25.22K derived: sum of 2 quarters · filed 2021-11-12 | $366.38K 10-Q · filed 2021-11-12 | $437.57K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$35.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $305.18K 10-Q · filed 2021-08-13 | $376.37K derived: sum of 3 quarters · filed 2021-08-13 | $499.98K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $341.17K 10-Q · filed 2021-05-14 | $412.35K derived: sum of 2 quarters · filed 2021-05-14 | $535.96K derived: sum of 3 quarters · filed 2021-05-14 | $674.15K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $71.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $194.79K derived: sum of 2 quarters · filed 2021-03-26 | $332.98K derived: sum of 3 quarters · filed 2021-03-26 | $478.92K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $123.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $261.80K derived: sum of 2 quarters · filed 2020-11-13 | $407.73K 10-Q · filed 2020-11-13 | -$206.09K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $138.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $284.13K 10-Q · filed 2020-08-13 | -$329.70K derived: sum of 3 quarters · filed 2020-08-13 | -$583.25K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $145.94K 10-Q · filed 2020-05-14 | -$467.89K derived: sum of 2 quarters · filed 2020-05-14 | -$721.44K derived: sum of 3 quarters · filed 2020-05-14 | -$219.94K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$613.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$867.38K derived: sum of 2 quarters · filed 2020-03-30 | -$365.88K derived: sum of 3 quarters · filed 2020-03-30 | -$99.40K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$253.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $247.95K derived: sum of 2 quarters · filed 2019-11-14 | $514.43K 10-Q · filed 2019-11-14 | $484.73K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $501.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $767.98K 10-Q · filed 2019-08-14 | $738.28K derived: sum of 3 quarters · filed 2019-08-14 | $710.69K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $266.48K 10-Q · filed 2019-05-14 | $236.78K derived: sum of 2 quarters · filed 2019-05-14 | $209.19K derived: sum of 3 quarters · filed 2019-05-14 | -$45.92K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$29.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$57.29K derived: sum of 2 quarters · filed 2019-03-28 | -$312.40K derived: sum of 3 quarters · filed 2019-03-28 | -$51.02K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$27.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$282.70K derived: sum of 2 quarters · filed 2018-11-14 | -$21.32K 10-Q · filed 2018-11-14 | $366.97K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$255.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $6.26K 10-Q · filed 2018-08-14 | $394.56K derived: sum of 3 quarters · filed 2018-08-14 | $569.40K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $261.38K 10-Q · filed 2018-05-14 | -$261.38K 10-Q · filed 2017-05-11 | $649.68K derived: sum of 2 quarters · filed 2018-05-14 | $824.52K derived: sum of 3 quarters · filed 2018-05-14 | $1.42M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $388.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $563.14K derived: sum of 2 quarters · filed 2018-04-02 | $1.16M derived: sum of 3 quarters · filed 2018-04-02 | $1.10M 10-K · filed 2018-04-02 | -$1.10M 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $174.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $770.33K derived: sum of 2 quarters · filed 2017-11-14 | $709.26K 10-Q · filed 2017-11-14 | -$709.26K 10-Q · filed 2016-11-14 | $839.81K derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | $595.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $534.42K 10-Q · filed 2017-08-14 | -$534.42K 10-Q · filed 2016-08-11 | $664.97K derived: sum of 3 quarters · filed 2017-08-14 | $459.78K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | -$61.07K 10-Q · filed 2017-05-11 | $69.49K derived: sum of 2 quarters · filed 2017-05-11 | -$135.71K derived: sum of 3 quarters · filed 2017-05-11 | -$1.16M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $130.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$74.64K derived: sum of 2 quarters · filed 2017-03-31 | -$1.10M derived: sum of 3 quarters · filed 2017-03-31 | -$2.51M 10-K · filed 2017-03-31 | -$5.07M 10-K · filed 2016-03-30 | |||
| 2015-09-30 | -$205.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.23M derived: sum of 2 quarters · filed 2016-11-14 | -$2.64M 10-Q · filed 2016-11-14 | -$2.43M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$2.44M 10-Q · filed 2016-08-11 | -$2.23M derived: sum of 3 quarters · filed 2016-08-11 | -$1.89M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | -$1.41M 10-Q · filed 2016-05-16 | -$1.20M derived: sum of 2 quarters · filed 2016-05-16 | -$864.36K derived: sum of 3 quarters · filed 2016-05-16 | -$3.07M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $207.45K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $543.73K derived: sum of 2 quarters · filed 2016-03-30 | -$1.66M derived: sum of 3 quarters · filed 2016-03-30 | -$3.16M 10-K · filed 2016-03-30 | -$3.44M 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $336.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | -$1.87M derived: sum of 2 quarters · filed 2015-12-28 | -$3.37M 10-Q · filed 2015-12-28 | |||||
| 2014-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | -$3.71M 10-Q · filed 2015-12-28 | -$309.18K 10-Q · filed 2014-08-14 | |||||
| 2014-03-31 | -$1.50M 10-Q · filed 2015-12-28 | |||||||
| 2013-12-31 | $3.63M 10-K · filed 2015-12-28 | |||||||
| 2013-06-30 | -$468.51K 10-Q · filed 2014-08-14 | |||||||
| 2012-12-31 | -$1.10M 10-K · filed 2014-03-20 | |||||||
| 2011-12-31 | -$11.39M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |